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few number of cases of hemangiopericytoma of the 
prostate have been described worldwide. Feasibil-
ity of managing such a case with a combination of 
conservative surgery and adjuvant anti-malignancy 
treatment is unexplored. Here, we report a case of 
hemangiopericytoma of the prostate treated with lo-
cal excision, with preservation of prostate, followed 
by adjuvant radiotherapy and chemotherapy.
2.  CASE DESCRIPTION
A 56-year-old man attended our oncology unit with 
a history of excision of a prostatic nodule about 6 
weeks earlier. The patient initially attended a local 
doctor, reporting a history of increased frequency 
of micturition for 2 months and increased tempera-
ture for 1 month. Routine examination was normal, 
and urine culture was negative. The fever and pain 
subsided after treatment with antibiotics, but the 
increased frequency of micturition persisted. Digital 
rectal examination revealed a mildly enlarged nodular 
prostate, and pelvic sonography was done. A thick-
walled nodule (38×36×35 mm) was detected in the 
prostate. A computed tomography scan was not done 
at that time. Serum prostate-specific antigen (p s a) 
was 1 ng/mL. Cystoscopy showed no intravesicular 
lesions. Transrectal core needle biopsy diagnosed a 
probable case of alveolar rhabdomyosarcoma. The 
patient refused radical surgery, and only local exci-
sion of the prostatic nodule was done.
Histopathology of the excised nodule revealed a 
tumour composed of small vascular clefts and gaping 
vascular channels surrounded by spindle cells with 
round or oval plump nuclei. No hemorrhage or necro-
sis was seen. The tumour showed borderline atypia 
[4 of 10 high-power fields (4/10 h p f )]. Pathology 
margins for the excised prostatic nodule were nega-
tive. The tumour was diagnosed to be either a case 
of hemangiopericytoma, a solitary fibrous tumour, or 
a case of prostatic stromal proliferation of uncertain 
malignant potential. Immunohistochemistry found 
that the tumour cells expressed CD34, Bcl2 protein, 
Mic2, and vimentin, but were immunonegative for 
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Hemangiopericytoma is a malignant vascular tumour 
of soft tissue. Microscopically, the tumour shows 
tightly packed cellular areas surrounding thin-walled 
branching blood vessels. Traditionally these tumours 
are treated using wide surgical excision. Only a very 
few cases of hemangiopericytoma of the prostate 
have been described worldwide. The feasibility of 
managing such a case with a combination of con-
servative surgery and adjuvant anti-malignancy 
treatment is unexplored.
Here, we report a case of hemangiopericytoma of 
the prostate treated with local excision, with preserva-
tion of prostate, followed by adjuvant radiotherapy 
(40 Gy in 20 fractions to pelvis followed by 24 Gy in 
12 fractions as boost to prostate) and chemotherapy 
(doxorubicin and iphosphamide). Post-treatment 
computed tomography scan after 4 weeks showed 
regression of pelvic lymph nodes and a normal-
appearing prostate. Levels of serum prostate-specific 
and carcinogenic embryonic antigen were normal 
throughout the period of treatment. To date, follow-
up has been uneventful, except for occasional bouts 
of diarrhea.
We conclude that conservative surgery followed 
by adjuvant radiation and chemotherapy, with subse-
quent close follow-up, may adequately control local-
ized disease in selected cases of hemangiopericytoma 
of the prostate. The role of conservative surgery in 
tumours located at other sites has yet to be defined.
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1.  INTRODUCTION
Hemangiopericytoma is a malignant vascular tumour 
of soft tissue. Microscopically, the tumour shows 
tightly packed cellular areas surrounding thin-walled 
branching blood vessels. Traditionally, these tumours 
are treated by wide surgical excision. Only a very CHAKRABARTI et al.
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HMB45, synaptophysin, and chromogranin. Hence, 
a diagnosis of hemangiopericytoma was made.
Postoperative magnetic resonance imaging 
showed no residual prostatic nodule. Prostate was 
normal in size, but irregular in shape, and enlarged 
pelvic lymph nodes were reported on imaging. Image-
guided biopsy of the nodes demonstrated spindle cells 
around branching vascular channels. Routine meta-
static work-up, serum p s a, and serum carcinogenic 
embryonic antigen (c e a ) levels were normal.
The patient refused any form of further surgery. 
Simple local excision of the prostatic nodule with-
out any adjuvant treatment would not have sufficed, 
because positive pelvic nodes had been left behind. 
The patient was therefore given good supportive care 
and was treated postoperatively with external-beam 
radiotherapy followed by 6 cycles of adjuvant com-
bination chemotherapy. External-beam radiotherapy 
was delivered using three-dimensional computerized 
treatment planning in a 3-field technique (1 anterior 
and 2 posterior oblique) delivering a dose of 40 Gy 
in 20 fractions to pelvis, followed by 24 Gy in 12 
fractions as a boost to prostate, with adequate margin. 
Adjuvant combination chemotherapy delivered at in-
tervals of 3 weeks consisted of doxorubicin 60 mg/m2 
on day 1 and iphosphamide 2 g/m2 daily for 4 days, 
together with m e s n a  and filgrastim support.
A c t scan 4 weeks after completion of treatment 
showed regression of the lymph nodes and a normal-
appearing prostate. Serum p s a and c e a were normal 
throughout the period of treatment. Patient has been 
followed in our department for 42 months to the date of 
writing. He is asymptomatic, and follow-up has been 
uneventful, except for occasional bouts of diarrhea.
3.  DISCUSSION
Hemangiopericytoma is an unusual perivascular 
tumour first described by Stout and Murray in 
1942 1. It features uncontrolled proliferation of peri-
cytes, which are cells described by Zimmermann 
in 1923 2,3. The tumour represents 2%–3% of all 
soft-tissue sarcomas in humans. It usually occurs in 
elderly patients during the 4th and 5th decades. The 
common sites are deep soft tissue, lower extremities, 
pelvis, and retroperitoneum 4. Head-and-neck lesions 
are also reported 5–9, and rare cases of primary he-
mangiopericytoma of bone may be found in pelvis, 
proximal femur, vertebrae, or humerus.
This tumour is generally rare in the urogenital 
system including the kidney; the other sites include 
the bladder, the prostate, and the spermatic cord 10–12. 
Hemangiopericytoma usually presents as a painless 
mass 4. Initial symptoms of the rare genitourinary 
tumours included hematuria, frequency of urina-
tion 11, and lower urinary tract obstruction 10.
Macroscopically, the tumour is soft and rub-
bery; microscopically, it is characterized by tightly 
packed small spindle cells surrounding thin-walled 
branching blood vessels (“stag horn” pattern). Mi-
croscopically, benign and malignant forms are dis-
tinguishable 11. Malignant forms are characterized 
by increased cellularity, prominent mitotic activity, 
and foci of necrosis or hemorrhage 4. Features indi-
cating poor prognosis include increased cellularity, 
necrosis, hemorrhage, and mitotic figures exceeding 
4/10 h p f  13. Tumours exhibiting nuclear atypia with 
more than 4/10 h p f may either recur or metastasize. 
Metastases are usually to lung and bone; lymph node 
metastasis is uncommon.
The spread pattern is principally hematogenous 2. 
Invasion of the bladder wall in urogenital tumours 
has been reported 10. Recurrence precedes metastasis 
in more than two thirds of patients with evidence 
of metastasis. The 10-year survival rate is 70%. 
The overall 5-year survival rate for microscopically 
dysplastic hemangiopericytoma is somewhat less 
than 50%.
The differential diagnosis of this lesion in prostate 
includes malignant fibrous histiocytoma, sarcomas, 
malignant peripheral nerve sheath tumour, and sar-
comatoid carcinoma. Differentiation uses immuno-
histochemistry. Tissue immunohistochemistry shows 
immunoreactivity for vimentin (variable intensity), 
factor xiiia antigen, h l a-d r  antigen, and CD34. No 
staining or reaction with factor viii–related antigen, 
Ulex europaeus  i lectin, α-smooth muscle actin, 
desmin, myoglobin, low- or high-molecular weight 
cytokeratin, or epithelial membrane antigen occurs.
Traditionally, these tumours are treated using 
surgical excision. Many authors have suggested 
that resectability may be the single most important 
determinant of clinical outcome 14. The role of 
adjuvant treatment is poorly defined. Use of adju-
vant radiation therapy reduces the risk of local and 
distant recurrence 2.
Only a very few cases of hemangiopericytoma 
of the prostate have been described worldwide 15–17. 
Some patients were treated with transurethral 
resection of the prostate 10, but they later died of 
late recurrence in up to 50% of cases 2 and dis-
seminated disease of the lung 3. The other patients 
were recommended to have early aggressive therapy 
and long-term follow-up 17. It was concluded that 
genitourinary tumours should be considered ma-
lignant and treated aggressively 12. The feasibility 
of managing such a case with a combination of 
conservative surgery and adjuvant anti-malignancy 
treatment had largely been unexplored.
4.  CONCLUSIONS
Conservative surgery followed by adjuvant radiation 
and chemotherapy, and subsequent close follow-up 
may adequately control localized disease in selected 
cases of hemangiopericytoma of the prostate. The role 
of conservative surgery in such tumours at other sites 
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